Search

everythinglearnresearchcommunity

for

Search:↓

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

AlopeciaDet accurately detects Alopecia Areata early using advanced image analysis.

Dermatology datasets need more diversity in skin tones and ethnic representation.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

Coudability hairs are useful markers for alopecia areata activity.

Machine learning optimized microneedles promote hair regrowth better than minoxidil without safety risks.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

A new tool can predict hair regrowth in patchy alopecia areata patients.

The document highlights advancements and findings in dermatology, including AI use, disease prevention, treatment efficacy, and the impact of conditions on patients' lives.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Engineered exosomes with EGF and FGF improve hair growth in mice with hair loss.

Standardized forms and digital tools can improve alopecia biopsy diagnosis.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Baricitinib is the most effective treatment for alopecia areata.

The tool accurately measures hair count and size on scalps with 79.45% and 68.19% accuracy, respectively.

The InCISE score is a promising tool for assessing wound healing in head and neck surgery but needs more research for broader use.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

The program improved students' understanding and acceptance of alopecia areata.

STITCH improves suture accuracy and efficiency, especially with human help.